UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 159

Sortiert nach

Reproductive healthcare utilization in patients with bleeding disorders

Journal of thrombosis and haemostasis, 2023-07, Vol.21 (7), p.1741-1743

2023

Volltextzugriff (PDF)

RNAing toward a new therapy for hemophilia

Blood, 2024-05, Vol.143 (22), p.2219

2024

Volltextzugriff (PDF)

“A New Hemophilia Carrier Nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH”: Reply to comment

Journal of thrombosis and haemostasis, 2022-07, Vol.20 (7), p.1745-1746

Sidonio, Robert F.

2022

Volltextzugriff (PDF)

Unresolved hemostasis issues in haemophilia

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-04, Vol.30 (S3), p.70-77

2024

Volltextzugriff (PDF)

A cross‐sectional study of bleeding phenotype in haemophilia A carriers

British journal of haematology, 2015-07, Vol.170 (2), p.223-228

2015

Volltextzugriff (PDF)

Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-09, Vol.25 (5), p.789-796

2019

Volltextzugriff (PDF)

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH

Journal of thrombosis and haemostasis, 2021-08, Vol.19 (8), p.1883-1887

2021

Volltextzugriff (PDF)

Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-05, Vol.28 (S4), p.18-25

2022

Volltextzugriff (PDF)

Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-01, Vol.29 (1), p.404-407

2023

Volltextzugriff (PDF)

Discussing investigational AAV gene therapy with hemophilia patients: A guide

Blood reviews, 2021-05, Vol.47, p.100759-100759, Article 100759

2021

Volltextzugriff (PDF)

Hemophilia B (Factor IX Deficiency)

Hematology/oncology clinics of North America, 2021-12, Vol.35 (6), p.1143-1155

2021

Volltextzugriff (PDF)

Assessment of menstrual health in adolescent and young adults with sickle cell disease

Pediatric blood & cancer, 2024-01, Vol.71 (1), p.e30727-n/a

2024

Volltextzugriff (PDF)

Substitution therapy

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-02, Vol.27 (S3), p.53-59

2021

Volltextzugriff (PDF)

Diagnostic pitfalls and conundrums in type 1 von Willebrand disease

Hematology, 2022-12, Vol.2022 (1), p.618

2022

Volltextzugriff (PDF)

Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real-world retrospective multi-institutional cohort

American journal of hematology, 2023-10, Vol.98 (10), p.E285-E287

2023

Volltextzugriff (PDF)

Adequate menstrual suppression in adolescents with inherited bleeding disorders often requires multiple treatment changes: Retrospective cohort study of a multidisciplinary clinic

Pediatric blood & cancer, 2024-06, Vol.71 (6), p.e30944-n/a

2024

Volltextzugriff (PDF)

Plasma factor IX: The tip of the iceberg?

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-05, Vol.27 (3), p.329-331

2021

Volltextzugriff (PDF)

Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-07, Vol.30 (4), p.905-913

2024

Volltextzugriff (PDF)

Thrombin generation and implications for hemophilia therapies: A narrative review

Research and practice in thrombosis and haemostasis, 2023-01, Vol.7 (1), p.100018-100018, Article 100018

2023

Volltextzugriff (PDF)

Spontaneous bleeding and poor bleeding response with extended half‐life factor IX products: A survey of select US haemophilia treatment centres

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-05, Vol.26 (3), p.e128-e129

2020

Volltextzugriff (PDF)

Dental habits and oral health in children and adolescents with bleeding disorders: A single‐institution cross‐sectional study

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-01, Vol.28 (1), p.73-79

2022

Volltextzugriff (PDF)

Depression and anxiety in persons with Von Willebrand disease

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-03, Vol.29 (2), p.545-554

2023

Volltextzugriff (PDF)

Novel therapeutics for hemophilia and other bleeding disorders

Blood, 2018-07, Vol.132 (1), p.23-30

2018

Volltextzugriff (PDF)

Potential Undiagnosed VWD Or Other Mucocutaneous Bleeding Disorder Cases Estimated From Private Medical Insurance Claims

Journal of blood medicine, 2020-01, Vol.11, p.1-11

2020

Volltextzugriff (PDF)

TFPI blockade: removing coagulation's brakes

Blood, 2019-11, Vol.134 (22), p.1885-1887

2019

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis Current Content Access

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(152)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Reproductive healthcare utilization in patients with bleeding disorders

RNAing toward a new therapy for hemophilia

“A New Hemophilia Carrier Nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH”: Reply to comment

Unresolved hemostasis issues in haemophilia

A cross‐sectional study of bleeding phenotype in haemophilia A carriers

Immune tolerance induction in paediatric patients with haemophilia A and inhibitors receiving emicizumab prophylaxis

A new hemophilia carrier nomenclature to define hemophilia in women and girls: Communication from the SSC of the ISTH

Health issues in women and girls affected by haemophilia with a focus on nomenclature, heavy menstrual bleeding, and musculoskeletal issues

Pharmacokinetic parameters of recombinant factor IX Fc fusion protein are not influenced by factor IX antigen levels in subjects from the Phase 3 B‐LONG trial

Discussing investigational AAV gene therapy with hemophilia patients: A guide

Hemophilia B (Factor IX Deficiency)

Assessment of menstrual health in adolescent and young adults with sickle cell disease

Substitution therapy

Diagnostic pitfalls and conundrums in type 1 von Willebrand disease

Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis: Real-world retrospective multi-institutional cohort

Adequate menstrual suppression in adolescents with inherited bleeding disorders often requires multiple treatment changes: Retrospective cohort study of a multidisciplinary clinic

Plasma factor IX: The tip of the iceberg?

Transitioning from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: A simulation study for individuals with severe haemophilia A

Thrombin generation and implications for hemophilia therapies: A narrative review

Spontaneous bleeding and poor bleeding response with extended half‐life factor IX products: A survey of select US haemophilia treatment centres

Dental habits and oral health in children and adolescents with bleeding disorders: A single‐institution cross‐sectional study

Depression and anxiety in persons with Von Willebrand disease

Novel therapeutics for hemophilia and other bleeding disorders

Potential Undiagnosed VWD Or Other Mucocutaneous Bleeding Disorder Cases Estimated From Private Medical Insurance Claims

TFPI blockade: removing coagulation's brakes

Aktive Filter

Suchergebnisse filtern